Glutathione-sensitive hollow mesoporous silica nanoparticles for controlled drug delivery

被引:113
|
作者
Moghaddam, Seyyed Pouya Hadipour [1 ,2 ]
Yazdimamaghani, Mostafa [1 ,2 ]
Ghandehari, Hamidreza [1 ,2 ,3 ]
机构
[1] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA
[2] Univ Utah, Nano Inst Utah, Utah Ctr Nanomed, Salt Lake City, UT 84112 USA
[3] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA
关键词
Tunable; Structural difference; Hollow mesoporous silica nanoparticles; GSH-sensitive; Degradable; High loading capacity; BRIDGED SILSESQUIOXANE NANOPARTICLES; LYSOSOMAL THIOL REDUCTASE; IN-VITRO; ORGANOSILICA NANOPARTICLES; THERAPY; CELLS; VIVO; PLATFORM; PATHWAY; AGENTS;
D O I
10.1016/j.jconrel.2018.04.032
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Tunable glutathione (GSH)-sensitive hollow mesoporous silica nanoparticles (HMSiO2 NPs) were developed using a structural difference-based selective etching strategy. These organosilica hollow nanoparticles contained disulfide linkages (S-S) in the outer shell which were degraded by GSH. The particles were compared with their nonGSH-sensitive tetraethyl orthosilicate (TEOS) HMSiO2 counterparts in terms of their synthesis method, characterization, doxorubicin (DOX) release profile, and in vitro cytotoxicity in MCF-7 breast cancer cells. Transmission electron microscopy (TEM) of the particles indicated that the fabricated HMSiO2 NPs had an average diameter of 130 +/- 5 nm. Thermogravimetric analysis (TGA) revealed that GSH-sensitive particles had approximately 5.3% more weight loss than TEOS HMSiO2 NPs. Zeta potential of these redox-responsive particles was -23 +/- 1 mV at pH 6 in deionized (DI) water. Nitrogen adsorption-desorption isotherm revealed that the surface area of the hollow mesoporous nanoreservoirs was roughly 446 +/- 6 m(2) g(-1) and the average diameter of the pores was 2.3 +/- 0.5 nm. TEM images suggest that the nanoparticles started to lose mass integrity from Day 1. The particles showed a high loading capacity for DOX (8.9 +/- 0.5%) as a model drug, due to the large voids existing in the hollow structures. Approximately 58% of the incorporated DOX released within 14 days in phosphate buffered saline (PBS) at pH 6 and in the presence of 10mM of GSH, mimicking intracellular tumor microenvironment while release from TEOS HMSiO2 NPs was only c.a. 18%. The uptake of these hollow nanospheres by MCF-7 cells and RAW 264.7 macrophages was evaluated using TEM and confocal microscopy. The nanospheres were shown to accumulate in the endolysosomal compartments after incubation for 24 h with the maximum uptake of c.a. 2.1 +/- 0.3% and 5.2 +/- 0.4%, respectively. Cytotoxicity of the nanospheres was investigated using CCK-8 assay. Results indicate that intact hollow particles (both GSH-sensitive and TEOS HMSiO2 NPs) were nontoxic to MCF-7 cells after incubation for 24 h within the concentration range of 0-1000 mu g ml(-1). DOX-loaded GSH-sensitive nanospheres containing 6 mu g ml(-1) of DOX killed c.a. 51% of MCF-7 cells after 24 h while TEOS HMSiO2 NPs killed c. a. 20% with the difference being statistically significant. Finally, cytotoxicity data in RAW 264.7 macrophages and NIH 3T3 fibroblasts shows that intact GSH-sensitive HMSiO2 NPs did not show any toxic effects on these cells with the concentrations equal or < 125 mu g ml(-1).
引用
收藏
页码:62 / 75
页数:14
相关论文
共 50 条
  • [1] Hollow Mesoporous Silica Nanoparticles with Tunable Structures for Controlled Drug Delivery
    Li, Yanhua
    Li, Na
    Pan, Wei
    Yu, Zhengze
    Yang, Limin
    Tang, Bo
    ACS APPLIED MATERIALS & INTERFACES, 2017, 9 (03) : 2123 - 2129
  • [2] Glutathione-responsive mesoporous silica nanoparticles with cyclodextrin gatekeepers for controlled drug delivery
    Lee, Jeonghun
    Kim, Min Ji
    Choi, Ji Woong
    Lee, Hyemi
    Park, Heon Joo
    Kim, Chulhee
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [3] Tumor targeted drug delivery with hollow mesoporous silica nanoparticles
    Chen, Feng
    Hong, Hao
    Shi, Sixiang
    Valdovinos, Hector
    Barnhart, Todd
    Cai, Weibo
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [4] Mesoporous Silica Nanoparticles for Intracellular Controlled Drug Delivery
    Vivero-Escoto, Juan L.
    Slowing, Igor I.
    Trewyn, Brian G.
    Lin, Victor S. -Y.
    SMALL, 2010, 6 (18) : 1952 - 1967
  • [5] PEGylated hollow mesoporous silica nanoparticles as potential drug delivery vehicles
    Zhu, Yufang
    Fang, Ying
    Borchardt, Lars
    Kaskel, Stefan
    MICROPOROUS AND MESOPOROUS MATERIALS, 2011, 141 (1-3) : 199 - 206
  • [6] Mechanized nanomachines on mesoporous silica nanoparticles for controlled drug delivery
    Dong, Juyao
    Zink, Jeffrey I.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [7] Silica-based mesoporous nanoparticles for controlled drug delivery
    Kwon, Sooyeon
    Singh, Rajendra K.
    Perez, Roman A.
    Abou Neel, Ensanya A.
    Kim, Hae-Won
    Chrzanowski, Wojciech
    JOURNAL OF TISSUE ENGINEERING, 2013, 4 (01) : 1 - 18
  • [8] Hollow silica–polyelectrolyte composite nanoparticles for controlled drug delivery
    Qingsong Yang
    Li Li
    Fang Zhao
    Haoya Han
    Weihua Wang
    Yuchuan Tian
    Yunwei Wang
    Zhishuang Ye
    Xuhong Guo
    Journal of Materials Science, 2019, 54 : 2552 - 2565
  • [9] Glutathione-sensitive mesoporous nanoparticles loaded with cinnamaldehyde for chemodynamic and immunological therapy of cancer
    Zhu, Lichong
    Li, Wenyue
    Liu, Chuang
    Yue, Saisai
    Qiao, Yuanyuan
    Cui, Yingying
    Cheng, Junwei
    Zhang, Ming
    Zhang, Peisen
    Zhang, Beibei
    Hou, Yi
    JOURNAL OF MATERIALS CHEMISTRY B, 2023, 11 (36) : 8717 - 8731
  • [10] Glutathione-Sensitive Nanogels for Drug Release
    Adamo, Giorgia
    Grimaldi, Natascia
    Campora, Simona
    Sabatino, Maria Antonietta
    Dispenza, Clelia
    Ghersi, Giulio
    IBIC2014: 4TH INTERNATIONAL CONFERENCE ON INDUSTRIAL BIOTECHNOLOGY, 2014, 38 : 457 - 462